256 related articles for article (PubMed ID: 9405727)
1. Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta.
Reinus WR; McAlister WH; Schranck F; Chines A; Whyte MP
Calcif Tissue Int; 1998 Jan; 62(1):17-20. PubMed ID: 9405727
[TBL] [Abstract][Full Text] [Related]
2. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate.
Lindahl K; Kindmark A; Rubin CJ; Malmgren B; Grigelioniene G; Söderhäll S; Ljunggren Ö; Åström E
Bone; 2016 Jun; 87():11-8. PubMed ID: 26957348
[TBL] [Abstract][Full Text] [Related]
3. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
[TBL] [Abstract][Full Text] [Related]
4. Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta.
Kocijan R; Muschitz C; Haschka J; Hans D; Nia A; Geroldinger A; Ardelt M; Wakolbinger R; Resch H
Osteoporos Int; 2015 Oct; 26(10):2431-40. PubMed ID: 25956285
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up in osteogenesis imperfecta type VI.
Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
[TBL] [Abstract][Full Text] [Related]
6. Lumbar spine bone mineral density Z-score discrepancies by dual X-ray absorptiometry do not predict vertebral fractures in children.
Harindhanavudhi T; Petryk A; Jones R; Regodón Wallin A; Hodges JS; Nortwick SV; Miller BS; Holm TL; Sarafoglou K
J Investig Med; 2018 Aug; 66(6):980-985. PubMed ID: 29622758
[TBL] [Abstract][Full Text] [Related]
7. Changes in trabecular bone density in incident pediatric Crohn's disease: a comparison of imaging methods.
Tsampalieros A; Berkenstock MK; Zemel BS; Griffin L; Shults J; Burnham JM; Baldassano RN; Leonard MB
Osteoporos Int; 2014 Jul; 25(7):1875-83. PubMed ID: 24760243
[TBL] [Abstract][Full Text] [Related]
8. Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
Bradbury LA; Barlow S; Geoghegan F; Hannon RA; Stuckey SL; Wass JA; Russell RG; Brown MA; Duncan EL
Osteoporos Int; 2012 Jan; 23(1):285-94. PubMed ID: 21739105
[TBL] [Abstract][Full Text] [Related]
9. High and low density in the same bone: a study on children and adolescents with mild osteogenesis imperfecta.
Rauch F; Land C; Cornibert S; Schoenau E; Glorieux FH
Bone; 2005 Nov; 37(5):634-41. PubMed ID: 16112635
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.
Letocha AD; Cintas HL; Troendle JF; Reynolds JC; Cann CE; Chernoff EJ; Hill SC; Gerber LH; Marini JC
J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638
[TBL] [Abstract][Full Text] [Related]
11. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
Land C; Rauch F; Travers R; Glorieux FH
Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
[TBL] [Abstract][Full Text] [Related]
12. Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta.
Watanabe G; Kawaguchi S; Matsuyama T; Yamashita T
Spine (Phila Pa 1976); 2007 Aug; 32(17):E488-94. PubMed ID: 17762282
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for low bone mineral density in pediatric inflammatory bowel disease: the positive role of physical activity.
Nobile S; Grand RJ; Pappa HM
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):471-476. PubMed ID: 29438136
[TBL] [Abstract][Full Text] [Related]
15. Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.
Land C; Rauch F; Munns CF; Sahebjam S; Glorieux FH
Bone; 2006 Oct; 39(4):901-6. PubMed ID: 16730480
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of Recurrent Fracture in a Pediatric Cohort.
Fiscaletti M; Coorey CP; Biggin A; Briody J; Little DG; Schindeler A; Munns CF
Calcif Tissue Int; 2018 Nov; 103(5):529-539. PubMed ID: 29943187
[TBL] [Abstract][Full Text] [Related]
17. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.
Zeitlin L; Rauch F; Plotkin H; Glorieux FH
Pediatrics; 2003 May; 111(5 Pt 1):1030-6. PubMed ID: 12728084
[TBL] [Abstract][Full Text] [Related]
18. Individualized evaluation of lumbar bone mineral density in children with cerebral palsy.
Duran I; Katzmann J; Martakis K; Stark C; Semler O; Schoenau E
Arch Osteoporos; 2018 Nov; 13(1):120. PubMed ID: 30397843
[TBL] [Abstract][Full Text] [Related]
19. Vertebral bone mass, size, and volumetric density in women with spinal fractures.
Duan Y; Parfitt Am; Seeman E
J Bone Miner Res; 1999 Oct; 14(10):1796-802. PubMed ID: 10491228
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density of the lumbar spine of Brazilian children and adolescents aged 6 to 14 years.
Fonseca AS; Szejnfeld VL; Terreri MT; Goldenberg J; Ferraz MB; Hilário MO
Braz J Med Biol Res; 2001 Mar; 34(3):347-52. PubMed ID: 11262585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
